Back

Altered fibrin clot properties and elevated von Willebrand Factors level are associated with progression to permanent atrial fibrillation during follow-up: a cohort study

31 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Risk assessment and prevention of brain infarction in atrial fibrillation Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Karol Witold Nowak

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

8 More presentations in this session

Presentation thumbnail
Incidence of silent brain injury in pacemaker implanted patients with atrial high-speed episodes (AHRE)
Doctor M. Uyanik (Samsun, TR)
Abstract Slides Video
Presentation thumbnail
The triglyceride-glucose index is a marker of thromboembolic events in atrial fibrillation patient under oral anticoagulation therapy
Doctor J. Rivera-Caravaca (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Resolution of silent left atrial thrombi and clinical outcomes in patients with atrial fibrillation: insight from the LAT trial
Doctor N. Tanaka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation
Associate Professor Z. Hijazi (Uppsala, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk assessment and prevention of brain infarction in atrial fibrillation

The Event

Event poster

ESC Congress 2024

31 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Session
Registries, observational, and other studies on atrial fibrillation
thumbnail
Congress Presentation
Atrial fibrillation progression and burden: how to define and measure
thumbnail
Congress Session
Atrial fibrillation: clinical 1

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources